Chromogranin A and NSE in cystic pancreatic neuroendocrine tumors
Authors:
- Sandra FaiasSFSandra Faias
- Susana PrazeresSPSusana Prazeres
- Mario CunhaMario Cunha
- Luisa PereiraLPLuisa Pereira
- Ruben RoqueRuben Roque
- Paula ChavesPCPaula Chaves
- Marília CravoMCMarília Cravo
- Isabel ClaroICIsabel Claro
- Margarida SilveiraMSMargarida Silveira
- Valeriano LeiteVLValeriano Leite
- A. Dias PereiraAPA. Dias Pereira
- 1 July 2021
- journal article
- letter
- Published by Elsevier in Clinics and Research in Hepatology and Gastroenterology
- Vol. 45 (4) , 101601
Abstract
No abstract availableKeywords
Funding Information
- Sociedade Portuguesa de Cardiologia
This publication has 9 references indexed in Scilit:
- Clinicopathological characteristics of non-functioning cystic pancreatic neuroendocrine tumorsPancreatology, 2019
- Pancreatic neuroendocrine carcinomas reveal a closer relationship to ductal adenocarcinomas than to neuroendocrine tumors G3Human Pathology, 2018
- Chromogranin A as circulating marker for diagnosis and management of neuroendocrine neoplasms: more flaws than fameEndocrine-Related Cancer, 2018
- Tumor Markers in Pancreatic Cystic Fluids for Diagnosis of Malignant CystsThe International Journal of Biological Markers, 2017
- Cystic fluid chromogranin A levels in different pancreatic cystic lesionsTurkish Journal of Gastroenterology, 2015
- Cystic pancreatic neuroendocrine tumors: The value of cytology in preoperative diagnosisCancer Cytopathology, 2014
- Endosonographic and cyst fluid characteristics of cystic pancreatic neuroendocrine tumours: A multicentre case seriesDigestive and Liver Disease, 2013
- Primary pancreatic cystic neoplasms of the pancreas revisited. Part IV: Rare cystic neoplasmsSurgical Oncology, 2012
- Prevalence of Unsuspected Pancreatic Cysts on MDCTAmerican Journal of Roentgenology, 2008